logo
episode-header-image
Sep 2025
9m 54s

AI, Polygenic Risk Scores, and Antithrom...

AMERICAN COLLEGE OF CARDIOLOGY
About this episode
tail spinning
Up next
Nov 24
December 2, 2025: Global CVD 1990–2023: Trends, Risks, and the Road Ahead | JACC This Week
<p>In the December 2, 2025 episode of JACC This Week, Editor-in-Chief Harlan M. Krumholz, MD, SM, introduces the Spotlight Issue, anchored by the manuscript "<a href= "https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015">Global, Regional, and National Burden of Cardiovascular Dis ... Show More
11m 5s
Nov 17
November 25, 2025: Clonal Hematopoiesis, Alcohol and Blood Pressure, Long-Term Risk, and Emerging Biomarkers | JACC This Week
<p>JACC's November 25, 2025 issue kicks off Thanksgiving week with JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, reflecting on his editor's page and <a href= "https://www.jacc.org/doi/10.1016/j.jacc.2025.10.024">the day he became a doctor</a> (0:12).  For original research art ... Show More
16m 18s
Nov 10
November 18, 2025: Adiposity, Heart Failure, and the Future of Cardiometabolic Care | JACC This Week
In the November 18, 2025 issue of JACC, Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, uses his editor's page to reflect on the evolving role of editors as partners with authors in strengthening cardiovascular science. The issue itself centers on adiposity, featuring multiple ... Show More
23m 9s
Recommended Episodes
Sep 2025
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More
31m 5s
Jun 2025
Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ... Show More
9m 15s
Jan 2025
Aortic Aneurysm and Dissection
In this episode of Spoonful of Sugar, host Eishan Ashwat, a medical student at the University of Pittsburgh, dives into the essential yet often life-threatening topics of aortic aneurysms and dissections. Starting with a clinical vignette to set the stage, Eishan explores the ana ... Show More
18m 58s
Aug 2025
425. Case Report: The Hidden Culprit – Unraveling the Cause of Malignant Ventricular Arrhythmias in a Young Adult – Trinity Health Livonia Hospital
CardioNerds guest host Dr. Colin Blumenthal joins Dr. Juma Bin Firos and Dr. Aishwarya Verma from the Trinity Health Livonia Hospital to discuss a fascinating case involving malignant ventricular arrhythmias. Expert commentary is provided by Dr. Mohammad-Ali Jazayeri. Audio editi ... Show More
54m 43s
Jun 2024
#305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson
tail spinning
1h 51m
May 2025
WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease
tail spinning
10m 53s
Nov 2024
399. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #37 with Dr. Clyde Yancy
The following question refers to Section 7.4 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by the Director of the CardioNerds Internship Dr. Akiva Rosenzveig, answered first by Vanderbilt AHFT cardiology fellow Dr. Jenna Skowronski, ... Show More
8m 40s
Jul 2024
Jul 12 2024 This Week in Cardiology
<p>Venous closure devices, GLP1-s linked to blindness and cancer, resisting the urge to do an ECG, and transcatheter edge-to-edge repair (TEER) for secondary mitral regurgitation are the topics discussed this week.</p> <p><em>This podcast is intended for healthcare professionals ... Show More
29m 3s
Feb 2025
#334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, cholesterol, brain health, and more | Tom Dayspring, M.D.
tail spinning
2h 17m
Nov 12
Peripheral Vasopressors, Practically Safe: What a 250-Patient Prospective Cohort Means for Your Unit
A new prospective multicenter cohort of 250 patients with shock examines the safety and outcomes of peripheral vasopressor administration. Extravasation events were rare and clustered only after several days of infusion, while norepinephrine use and simple physiologic markers cor ... Show More
7m 32s